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Amphiphilic poly(esteracetal)s as dual pH- and
enzyme-responsive micellar immunodrug delivery
systems†
Leon Bixenmann, Judith Stickdorn and Lutz Nuhn *
Poly(esteracetal)s are equipped with both acid-labile acetal and base-labile ester functionalities in their
backbone, thus, providing dual pH-responsive degradation proﬁles. In this study, the cyclic esteracetal
monomer 2-methyl-1,3-dioxan-4-one (MDO) was polymerised via a cationic ring-opening mechanism
onto methoxy poly(ethylene glycol) (mPEG) aﬀording amphiphilic mPEG-b-P(MDO) poly(esteracetal)
block copolymers that self-assemble into well-deﬁned monomodal micelles by direct hydration with
aqueous buﬀers. Their pH-responsive behaviour towards rapid particle degradation was conﬁrmed by
DLS and 1H-NMR. Upon acidiﬁcation or basiﬁcation and lipase-mediated enzymatic hydrolysis, immediate
polymer degradation and cargo release could be observed. As an example for further suitable appli-
cations, an amphiphilic immune stimulatory TLR-7 agonist (Adifectin) was co-formulated into mPEG-b-P
(MDO) block copolymer micelles and its activity was investigated by TLR stimulation of RAW Blue macro-
phages. The degradable amphiphilic block copolymer was able to solubilize the drug more eﬃciently and
retained its receptor activity. Consequently, mPEG-b-P(MDO) based amphiphilic poly(esteracetal)s can be
considered as promising delivery systems for further immunodrugs and, thus, may contribute towards
improving their translatability.
1. Introduction
Delivering pharmaceutically active molecules to their specific
therapeutic target by using nanosized carrier systems has
attracted major interest to overcome current limitations of
drug therapies.1,2 Many hydrophobic drugs suﬀer from low
solubility and unspecific binding which cause non-controlla-
ble toxicities.3,4 This includes novel promising anticancer or
immune therapeutics which accumulate insuﬃciently at their
target sites. As a result, their related oﬀ-target eﬀects limit any
clinical translatability. In that context, amphiphilic block copo-
lymers may support the drugs when formulated into nano-
metre-sized micellar delivery systems. They are structurally
composed of a hydrophilic corona and a hydrophobic core
where the therapeutic compounds can be entrapped
physically.2,5–7 The size, surface properties and responsive
behaviour of the micelles can determine the accessibility and
tissue accumulation of drugs.8 Many attempts have been made
to translate this general principle into clinical practice includ-
ing paclitaxel formulations such as Genexol-PM, which was
approved in 2007 in South Korea for breast cancer.4,7,9
In parallel, novel therapeutic antitumour concepts
have evolved over the last decade, especially with respect to the
role of the immune system in cancer progression. Scientists
envision reinforcing immune reactions against cancer cells
by delivering immune-stimulating therapeutics to the tumour
microenvironment and its draining lymph nodes.6,10
Immunostimulants such as the Toll-like receptor (TLR) 7
agonist imiquimod are highly potent in inducing innate
immune responses and result in an activation of a broad spec-
trum of antigen-presenting cells and suﬃcient activation of
cytotoxic T-cells. Unfortunately, if administered systemically,
uncontrolled inflammations are elicited also in healthy tissues
leading to severe side eﬀects.11 To overcome these dose-limit-
ing toxicities, nanocarriers are considered as ideal delivery
vehicles especially for such small molecular immunotherapeu-
tics, e.g. to enhance their transport, release and activity in the
lymph nodes.12–14 Consequently, a fundamental challenge is
to design carriers with suﬃcient tissue mobility to lymph
nodes that show at the same time appropriate uptake by rele-
vant immune cells.
Recently reported findings imply that lymph nodes can
exhibit acidic compartments that inhibit T-cell eﬀector func-
tions.15 Therefore, an acid triggered cleavage of the shielding
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corona followed by the release of immunotherapeutics might
be a beneficial strategy towards lymph node targeted delivery
of immune stimulatory drugs. As advanced multi-responsive
class of materials, poly(esteracetal)s can provide such acid-
cleavable features beyond classical ester hydrolysis (the latter
commonly guarantees avoiding long-term particle accumu-
lation by e.g. enzyme-mediated ester cleavage).
Poly(esteracetal)s are accessible by ring-opening polymeris-
ation and are gaining growing interest especially towards the
development of degradable polymers for sustainable
plastics.16–18 In this respect, Hillmyer and coworkers have
recently provided major contributions to a mechanistic under-
standing of their fabrication.17,18 In one of their seminal
works, Hillmyer et al. applied cationic ring-opening polymeris-
ation conditions to cyclic ester acetal monomers which pre-
vented the expulsion of acetaldehyde.18 Using the acidic
organocatalyst diphenyl phosphoric acid (DPP), they showed
successful poly(esteracetal) formation with diﬀerent end
groups based on the applied alcohol initiator. However, to the
best of our knowledge, a block copolymerisation with macroi-
nitiators towards amphiphilic diblock copolymers has so far
not been reported.
With the expansion of classical micellar drug carrier
systems, we believe that micelles derived from poly(esteracetal)
diblock copolymers are a promising platform for lymph node-
responsive delivery of immunotherapeutics. The acid-degrad-
able acetal group ensures rapid carrier degradation and cargo
release in acidic environments such as in immunosuppressive
cancers and their draining lymph nodes, while the ester func-
tionalities further enable long-term enzymatic carrier clear-
ance from the body. In this context, our work aims at provid-
ing first proof-of-concept studies on applying amphiphilic poly
(esteracetal)s in immunodrug delivery. In this respect, the
reported synthesis of poly(esteracetal) homopolymers initiated
by small molecular alcohols was adopted and successfully
modified towards amphiphilic block copolymerisation by
using mPEG as a macroinitiator. The self-assembly behaviour
of the resulting block copolymers was carefully investigated in
aqueous media. Thereby, the dual pH-responsive and enzy-
matic degradation profiles of the polymers and their derived
micelles could be confirmed by NMR spectroscopy, size
exclusion chromatography and dynamic light scattering. To
demonstrate the ability of solubilizing hydrophobic drug com-
pounds, poly(esteracetal) micelles were loaded with a hydro-
phobic dye and an amphiphilic immune stimulatory TLR7
agonist. Primary in vitro cell studies revealed low carrier toxici-
ties and successful TLR7 stimulation for the drug-loaded
micelles (Fig. 1). Altogether, our findings confirm the high
potential of amphiphilic poly(esteracetal)s in immunodrug
delivery and may contribute towards improving the translat-
ability of further promising immunodrugs.
2. Experimental section
2.1 Materials
Unless otherwise stated, all reagents were purchased from
Sigma-Aldrich or Fisher Scientific. 1,2-Dichloroethane (DCE)
and dichloromethane (DCM) as solvents were dried by heating
under reflux over calcium hydride for 3 h, and then stirred
overnight at room temperature and distilled prior to use. The
cyclic esteracetal monomer 2-methyl-1,3-dioxan-4-one (MDO)
was synthesized from commercial 2-methyltetrahydrofuran-3-
one, as has recently been reported.17 Prior to use, MDO was
dried over calcium hydride overnight at room temperature (rt)
and freshly distilled. Magnesium sulphate was obtained from
Acros Organics and diphenylphosphoric acid (DPP) was pur-
chased from Alfa Aesar. DPP was dried under high vacuum
(0.05 mbar) overnight. DPP-catalyst stock solutions were pre-
pared from dried DPP in either anhydrous 1,2-dichloroethane
or dichloromethane. Polyethylene glycol was purchased from
Fluka® Analytical. Prior to use, it was also dried by azeotropic
distillation with toluene three times and then left under high
vacuum (0.05 mbar) overnight. 120 mM phosphate buﬀer (10×
PB) was prepared from sodium hydrogen phosphate (100 mM)
and potassium dihydrogen phosphate (20 mM) diluted with
Fig. 1 (A) Synthesis and dual pH-responsive (or enzymatic) degradation of amphiphilic poly(esteracetal) block copolymers. (B) Schematic illustration
of the concept using amphiphilic poly(esteracetal) block copolymers and their derived micelles for pH- and lipase-responsive delivery of
immunodrugs.
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Millipore water. Millipore water was obtained from a Milli-Q
Reference A + System (water was used at a resistivity of 18.2
MΩ cm−1 and total organic carbon of < 5 ppm). Deuterated sol-
vents were obtained from Deutero. Deuterated toluene was
purchased from Sigma Aldrich. For enzymatic degradation
studies, a recombinant lipase immobilized on acrylic resin
beads was used (Novozyme 435 ≥ 5000 U g−1, recombinant,
expressed in Aspergillus niger, from Sigma Aldrich). The solid
support enables enzymatic polymer degradation studies both
in organic (toluene) and aqueous environments. Dialysis was
performed using Spectra/Por7 dialysis membranes with a
molecular weight cut-oﬀ of 1000 g mol−1. Sterile Dulbecco’s
PBS, cell culture medium and supplements were purchased
from Thermo Fisher. The RAW-Blue reporter cell line,
QUANTI-Blue reagent and Adifectin (CL347) were purchased
from Invivogen and handled as recommended by the supplier.
2.2 Instrumentation
All 1H-Nuclear Magnetic Resonance (NMR) spectra were
recorded at room temperature on a Bruker 250 MHz, 300 MHz,
400 MHz or 600 MHz FT NMR spectrometer (Bruker Avance III
250, Bruker Avance III HD 300, Bruker Avance II 400, or Bruker
Avance III 600). Chemical shifts (δ) are provided in parts per
million relative to TMS. NMR spectra were processed with
MestReNova 11.0.4 from Mestrelab Research. Samples were
prepared in respective deuterated solvents and their signals
referenced to the residual non-deuterated solvent signal.
Integrals of proton signals of the block copolymer were nor-
malized to the integral of the ethylene glycol units of mPEG,
which were set to 194 protons (Fig. S13†). This relative number
of protons has been determined from pure 2 kg mol−1 mPEG
by 1H-NMR referenced to its methyl end group. Diﬀusion
Ordered Spectroscopy (DOSY) spectra were recorded at room
temperature on a Bruker 400 MHz FT NMR spectrometer
(Bruker Avance III HD 400) and processed using Bayesian
DOSY Transformation (minimum: 1.00 × 10−8; maximum: 1.00
× 10−4; resolution factor: 1.00; repetition factor: 1; points in
dimension: 64). The molecular weights of the polymers were
determined using a size exclusion chromatography (SEC) set
up composed of an Agilent Series 1100 with THF as the mobile
phase (flow rate: 1 mL min−1) equipped with an SDV column.
Samples were run with toluene as an internal standard. All
measurements were performed using an RI (Agilent G1362A)
and UV (275 nm) detector. SEC data were analysed via WinGPC
Unity using a PEG calibration (Polymer Standards Service
Mainz). Dynamic light scattering (DLS) and zeta potential
measurements were performed on a Zetasizer Nano ZS
(Malvern Instruments Ltd, Malvern, U.K.) equipped with a
HeNe laser (λ = 633 nm) and detected at a scattering angle of
173° at 25 °C. The obtained data were processed by cumulant
fitting for z-average and PDI as well as by CONTIN fitting for
particle size distribution. Unless otherwise stated, dust was
removed from the sample prior to each measurement by fil-
tration through a GHP syringe filter (0.45 µm pore size,
Acrodisc). The zeta potential was measured by laser Doppler
electrophoresis using folded capillary cells (Malvern, DTS
1070). The eﬀective zeta potential was calculated using the
Smoluchowski approximation. MALDI-ToF mass spectra were
acquired on a rapiflexTM MALDI-ToF/ToF mass spectrometer
from Bruker equipped with a 10 kHz scanning smartbeam 3D
laser (Nd: YAG at 355 nm) and a 10 bit 5 GHz digitizer.
Measurements were performed in positive reflector mode
using DCTB (trans-2-[3-(4-tert-butylphenyl)-2-methyl-2-propeny-
lidene]malononitrile) acid as a matrix. The data were pro-
cessed with mMass and Origin 7.5/8.0. pH measurements were
performed using a pH-measuring instrument (Seven Compact)
manufactured by Mettler Toledo (standardized to pH 4, pH 7,
pH 10). UV/Vis spectra were recorded on a Jasco V-630 spectro-
photometer equipped with a Peltier thermostatted single cell
holder (JASCO ETC-717) cooled by a water thermostat
(A. Knüss Optronic V50) to guarantee measurement conditions
at 25.0 °C.
2.3 Synthesis of a 2-methyl-1,3-dioxan-4-one (MDO)
monomer
According to the literature,17 the cyclic esteracetal-monomer
2-methyl-1,3-dioxan-4-one (MDO) was synthesized from
racemic 2-methyldihydrofuran-3-one via Baeyer–Villiger oxi-
dation. 77% m-CPBA (69.17 g; 309 mmol; 1.2 eq.) was dissolved
in 600 mL methylene chloride (DCM), dried over MgSO4, and
filtered. With 100 mL of DCM, residual MgSO4 was rinsed and
filtered. The combined filtrates were transferred into a
2000 mL round bottom flask under a nitrogen atmosphere
and cooled to 0 °C. 2-Methyltetrahydrofuran-3-one (25 mL;
257.2 mmol; 1 eq.) was added stepwise via a syringe over a
time range of 30 minutes. The solution was then brought to
room temperature and stirred for a further 21.5 h. The precipi-
tated meta-chlorobenzoic acid was removed by repeated fil-
tration at −78 °C. The volume of the solution was then concen-
trated to 60 mL under vacuum and filtered once more. The fil-
trate was washed with saturated sodium bicarbonate (8 ×
20 mL) until no further carbon dioxide emission was
evident. The aqueous fractions were extracted three times
with DCM. The combined organic layers were washed with
10 mL of deionized water and subsequently dried over MgSO4.
Dichloromethane was removed by distillation. The crude oil
was transferred into a 50 mL round bottom flask, dried over
calcium hydride for 12 h at room temperature and sub-
sequently distilled via short path distillation apparatus (56 °C,
5 × 10−2 mbar). The product was obtained as a colourless
liquid (17.58 g; 151.40 mmol; 59%) and stored at −17 °C. The
purified product was characterised by 1H-, 13C-, COSY- and
HSQC-NMR spectroscopy. All spectra are provided in
Fig. S1–S4.†
1H-NMR (400 MHz, CDCl3) δ [ppm] = 5.39 (q, J = 5.1, 1H;
–O–CH(CH3)–O–), 4.17 (ddd, J = 11.5, 8.2, 2.3, 1H; –C(O)–CH2–
CH2–O–), 3.91 (ddd, J = 11.4, 10.7, 5.4, 1H; –C(O)–CH2–CH2–
O–), 2.75 (ddd, J = 17.8, 10.7, 8.2, 1H; –C(O)–CH2–CH2–O–),
2.56 (ddd, J = 17.9, 5.4, 2.3, 1H; –C(O)–CH2–CH2–O–), 1.45 (d,
J = 5.2, 3H; –O–CH(CH3)–O–).
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13C-NMR (100 MHz, CDCl3) δ [ppm] = 167.54 (–C(O)–);
101.17 (–O–CH(CH3)–O–); 63.33 (–C(O)–CH2–CH2–O–); 29.93
(–C(O)–CH2–CH2–O–); 21.12 (–O–CH(CH3)–O–).
2.4 Homopolymerisation of MDO
One day before polymerisation, pyrene butanol (35.15 mg;
0.13 mmol; 1/80 eq.) was weighed into a dried 5 mL Schlenk
flask, dried by azeotropic distillation with toluene three times
and further kept under high vacuum overnight. The polymeris-
ation of MDO was carried out under a nitrogen atmosphere
using dried glassware and a Teflon stir bar. MDO (1.0 mL;
10.25 mmol; 1 eq.) was added to pyrene butanol (volumetri-
cally by using a 1 mL syringe). 0.27 mL of dichloroethane
(DCE) was added as solvent. After complete solvation of all
compounds, DPP was added from a prepared stock solution
using a 1 mL syringe (200 µL of a 24.635 mM stock solution in
DCE; 4.93 µmol; the amount corresponds to a ratio of 1/2080
DPP/MDO). Conversion of MDO was determined by 1H-NMR.
After 24 h, polymerisation was quenched using triethylamine
(3.4 µL dissolved in 1 mL of DCM; 5 eq.) and stirred for
10 minutes. The crude product was subsequently purified by
repeating precipitation three times in 40 mL of a THF/
n-hexane solution (1 : 9). The precipitate was isolated by cen-
trifugation (4500 rpm, 20 min, 4 °C) and removal of the super-
natant. The remaining pellet was dissolved in 1 mL of DCM
and precipitated again. After drying under vacuum at room
temperature, 237 mg of poly(pyrene butanol-PMDO) was
obtained as a slightly yellowish, highly viscous liquid (19%
yield relative to 100% of the monomer). The homopolymer was
analysed by SEC, MALDI and 1H-NMR as well as 13C-NMR,
COSY, HSQC and HMBC spectroscopy. All data are provided in
Fig. S5–S12.†
SECUV (THF, PEG calibration): Mn = 2400 g mol
−1, PDI =
1.31.
1H-NMR (400 MHz, CDCl3) δ [ppm] = 8.33–7.79 (m, pyrene-
H); 5.96 (q, J = 5.2, 1H; –O–CH(CH3)–O–); 4.78–4.64 (m,
pyrene–(CH2)4–O–CH(CH3)–O–); 3.97–3.85 (m, 2H; –C(O)–CH2–
CHH–O–); 3.84–3.71 (m, 2H; –C(O)–CH2–CHH–O–); 3.37 (t, J =
7.6 Hz; pyrene–(CH2)–(CH2)); 2.59 (m, 2H; –C(O)–CH2–CH2–
O–); 2.09–2.00 (m; pyrene–(CH2)–(CH2)–(CH2)); 1.99–1.89 (m;
pyrene–(CH2)2–(CH2)), 1.37 (d, J = 5.3, 3H; –O–CH(CH3)–O–).
13C NMR (100 MHz, CDCl3) δ [ppm] = 170.95 (–C(O)–);
96.51 (–O–CH(CH3)–O–); 64.42 (–C(O)–CH2–CH2–O–); 35.16
(–C(O)–CH2–CH2–O–); 20.76 (–O–CH(CH3)–O–).
Polymerisation at 0 °C: yield 43%, SECUV (THF, PEG cali-
bration): Mn = 3700 g mol
−1, PDI = 1.79.
2.5 Block copolymerisation of MDO onto mPEG
As an example, the synthesis of mPEG48-b-P(MDO)50 is
described. One day before polymerisation, 129.36 mg
(64.9 µmol; 1/158 eq.) mPEG was weighed into a 10 mL
Schlenk tube equipped with a stir bar. For drying, 1 mL of
toluene was added and the suspension was stirred for 10 min.
Afterwards, the solution was frozen in liquid nitrogen and
dried under reduced pressure (0.05 mbar). This procedure was
repeated three times and the dried polymer was then kept at
0.05 mbar overnight. Into the prepared Schlenk tube equipped
with a stir bar and dried mPEG, MDO was added volumetri-
cally via a purged syringe (1 mL; 10.25 mmol 1 eq.). All com-
pounds were dissolved without adding an additional solvent.
Subsequently, 150 µL catalyst stock solution was added volu-
metrically (concentration: 32.846 mM stock solution in di-
chloromethane; 4.93 µmol; the amount corresponds to a ratio
of 1/2080 DPP : MDO). Then, polymerisation was conducted at
room temperature. Conversion of MDO was tracked by
1H-NMR. After 23 h, further conversion was marginal
(∼1 monomer unit per hour) and, therefore, the polymeris-
ation was quenched with triethylamine (1.5 eq.). (Note that in
order to find an appropriate purification method, previous
solubility experiments with pyrene butanol initiated homopo-
lymers were conducted. They indicated that homopolymers are
slightly soluble in diethyl ether, whereas mPEG precipitated
well.) Therefore, the crude product was repetitively precipitated
in Et2O three times at −17 °C. Whereas the crude product of
polymers with exceptionally shorter chain lengths precipitated
directly, the longer chains precipitated only after cooling. For
polymerisation conditions used at mPEG to monomer ratios of
95 and 126, the purified product was obtained as a colourless
solid (yield: 31%), whereas for higher ratios the product was
obtained as a viscous liquid. Summarized data of all reaction
conditions applied to obtain mPEG48-b-PMDO block copoly-
mers are summarized in Table 1. Each polymer was further
characterised by 1H-NMR, 13C-NMR, COSY, HMBC and HSQC
and diﬀusion ordered spectroscopy (DOSY), as well as SEC and
MALDI-ToF MS (compare Fig. S14–S30†).
SEC (THF, PEG calibration): Mn = 8800 g mol
−1, PDI = 1.65.
1H-NMR: (400 MHz, CDCl3) δ [ppm] = 5.96 (q, J = 5.3, 1H;
–O–CH(CH3)–O–); 4.77 (q, J = 5.3; mPEG–O–CH(CH3)–O–);
3.75–3.85 (m, 1H; –C(O)–CH2–CHH–O–); 3.98–3.85 (m, 1H; –C
(O)–CH2–CHH–O–); 3.64 (s, mPEG–(CH2–CH2–O–)); 3.38 (s;
(–CH3) methoxy-PEG), 2.67–2.50 (m, 4H; –C(O)–CH2–CH2–O–),
1.37 (d, J = 5.3, 3H; –O–CH(CH3)–O–).
13C-NMR: (100 MHz, CDCl3) δ [ppm] = 170.91(–C(O)–);
96.44 (–O–CH(CH3)–O–); 70.61 (mPEG–(CH2–CH2–O–), 64.36








mPEG48-b-P(MDO)15 95 44 15 3700 5000 1.46
mPEG48-b-P(MDO)23 126 44 23 4700 6000 1.57
mPEG48-b-P(MDO)50 158 55 50 7800 8800 1.65
mPEG48-b-P(MDO)71 190 54 71 10 200 10 300 1.48
χtargn : Initial monomer to initiator (= mPEG) ratio; con.: monomer
conversion during polymerisation determined by 1H-NMR prior to
polymer purification. χprodn : monomer to initiator (= mPEG) compo-
sition of the purified polymer determined by 1H-NMR using the reso-
nance signals of the poly(esteracetal) proton and referencing them to
the proton signals of the ethylene glycol units of PEG. Mprodn : calculated
molecular weight based on the χprodn of the monomer and adding the
molecular weight of the initiator (= 2 kDa mPEG). MSECn and Đ
SEC:
number average molecular weight and distribution determined by THF
SEC using mPEG calibration.
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(–C(O)–CH2–CH2–O–); 35.08 (–C(O)–CH2–CH2–O–); 20.71
(–O–CH(CH3)–O–).
2.6 Self-assembly process of mPEG-b-poly(MDO)
(a) Solvent switch method. Approximately 10 mg of the
diblock copolymer was dissolved in an appropriate volume of
DMSO to target a concentration of 5 mg ml−1. The solution
was dialyzed against 1 L of 1× phosphate buﬀered-saline solu-
tion at a pH of 7.4. In the first attempt, dialysis was carried out
over 4 days (the pH was checked to be neutral by using pH-
indicator strips (MERCK) before and after dialysis). The
solvent was exchanged every 24 hours. To prove preliminary
degradation, the dialyzed solution was extracted with DCM
and analysed via 1H-NMR in CDCl3 where only PEG as the
degradation product could be found (acetaldehyde and
3-hydroxypropionic acid are water-soluble and could not be
extracted). Therefore, for the subsequent micellar preparation,
the dialysis time was reduced to 8 h and the solvent exchanged
at 2 h intervals. Dialysis usually yielded a particle solution of
approximately 6 mL. Particles were subsequently measured by
DLS (Fig. S32 and Table S1†).
(b) Direct hydration technique. Approx. 4 mg of the
polymer was weighed in a 5 mL Eppendorf tube, and an appro-
priate volume of 120 mM phosphate buﬀer (adjusted to a pH
between 7.2 and 7.4) was added to target a concentration of
4 mg mL−1. After ten minutes of shaking, the dissolution
process was assisted by sonication for 15 min at 0 °C. Directly
after preparation, micellar size distribution was analysed by
DLS measurement at 25 °C (Fig. 3 and Fig. S33†).
(c) Critical micelle concentration (CMC) determination.
The critical micelle concentration was determined by analysing
the fluorescence intensities of solubilized pyrene’s first and
third vibronic band maxima I1 and I3 at 375 nm and 387 nm
(Fig. S34 and S35†). Their ratio I3/I1 was plotted versus logarith-
mic molar polymer concentration (Fig. S36 and S37†) and
linear extrapolations of the steady ratio and increase ratio were
used to determine their intercept as the CMC. For this
purpose, a 126.58 µM pyrene solution was first prepared by
dissolving 25.6 mg pyrene in 100 ml acetonitrile. 82.8 µL of
this solution was further diluted in 100 mL of acetonitrile to
aﬀord a 1 µM stock solution. Independently, three individual
solutions of the same block copolymers at 1 mg mL−1 were
prepared in acetonitrile, too, and then sequentially diluted.
For this purpose, 455 µL were serially diluted with 354 µL of
acetonitrile. To each sample of the prepared dilution series,
200 µL of the 1 µM pyrene stock solution was added.
Subsequently, all the organic solvent was removed in vacuo
within approximately 2 h aﬀording a polymer pyrene film. All
subsequent steps were performed as fast as possible to mini-
mize possible hydrolysis. 354 µL of 10× PB was added to each
polymer pyrene film. The samples were sonicated for 30 min
and repeatedly vortexed. Finally, 300 µL of each sample were
pipetted into black 96 well plates and measured immediately
using a microplate reader. Fluorescence emission was
recorded at room temperature with an excitation wavelength of
333 nm and monitored from 360 to 450 nm (step size: 1 nm).
2.7 Dual pH-responsive degradation studies
(a) NMR degradation kinetics (Fig. S43 and S44†). Micelles
were prepared via the dissolution method as described above.
8 mg mPEG48-b-P(MDO)15 was weighed in a 5 mL Eppendorf
tube, and 1 mL of 120 mM phosphate buﬀer prepared in D2O
was added. The pD value was measured with a glass electrode
standardized with aqueous buﬀer solutions at pH 4, 7 and 10.
The pH-value can be approximated19 using:
pHðbuffer of D2OÞ ¼ pHmeasured  0:41
Accordingly, the measured pD value of 7.5 correlates with a
buﬀer with a pH of 7.1. After degradation, the pD dropped to a
value of 7.0 which corresponds to a pH value of approx. 6.6.
After ten minutes of shaking, the dissolution process was
assisted by sonication at 0 °C for 15 min. Subsequently, NMR
analysis was conducted. The degradation was calculated by
subtracting the relative amount of 3-hydroxypropanoic acid
(determined by its proton signal referenced to the proton
signal of the HO–CH2– group) from the degree of polymeris-
ation determined in CDCl3.
(b) NMR analysis of micellar degradation products after
exposure to acidic and basic conditions. For acidic degra-
dation, micelles were prepared at a concentration of 8 mg
mL−1 in D2O. To 1 mL of micellar solution, 50 µL of 1 M HCl
or NaOH was added respectively and 1H-NMR spectra were
recorded 4 h after addition.
(c) SEC analysis of micelles after exposure to acidic and
basic conditions. The degraded NMR samples from 2.7.b were
analysed by THF-SEC. Before measurement, the pH was neu-
tralized. The solution was diluted with THF to approx. 4 mg
mL−1, filtered and analysed.
(d) DLS analysis of micelles after exposure to acidic and
basic conditions (Fig. 4A, Fig. S38 and S39†). To investigate
the micellar response to poly(esteracetal) degradation, micelles
were prepared via the direct dissolution method (as described
in 2.6.b) and again analysed via DLS. For this purpose, the
micelles were prepared in 120 mM phosphate buﬀer at pH 7.4.
After preparation, the micelles were observed for approxi-
mately 2 h confirming normal particle formation and stability,
and subsequently divided into three new cuvettes. To each of
them either 10 vol% of 1 M HCL, phosphate buﬀer or 1 M
NaOH was added. Subsequently, all probes were characterised
by DLS over time at given time points (addition of 1 M HCl
aﬀorded pH 5.7, phosphate buﬀer remained neutral at pH 7.2
and addition of 1 M NaOH resulted in pH 10.8).
(e) Zeta potential analysis of micelles immediately after
exposure to neutral, acidic and basic conditions (Fig. S40 and
S54†). To verify the proposed mechanism of micelle behaviour
in response to the change in pH, micelles were prepared (and
loaded, respectively) as described via the direct hydration tech-
nique at a concentration of 4 mg mL−1 in 5 mM HEPES buﬀer
(at pH 7.14) and subsequently used for zeta potential analysis.
The micelles were diluted threefold (300 µL of micellar solu-
tion with 600 µL of buﬀer), further acidified with 2 µL of 1 M
HCl (aﬀording a final pH ≈ 4), basified respectively with 3.5 µL
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of 1 M NaOH (aﬀording a final pH ≈ 10) and measured again.
Data are given as mean ± standard deviation of three repeated
measurements per sample.
2.8 Enzymatic degradation studies
(a) Enzymatic NMR degradation kinetics in toluene
(Fig. S45–S47†). The non-self-assembled block copolymers
could be degraded enzymatically by solid-supported lipase in
organic solvent. For this purpose, 19.55 mg of mPEG48-b-P
(MDO)71 was dissolved in 0.7 mL toluene-d8 and 25 mg of
Novozyme 435 was added. A sample without an enzyme served
as a negative control. The degradation was determined based
on the formation of acetaldehyde referenced to the aromatic
resonance signal of residual toluene. The signal ratio of the
intact polymer to toluene could be determined by NMR-ana-
lysis before enzyme addition.
(b) Enzymatic NMR degradation kinetics in D2O phosphate
buﬀer (Fig. 5 and Fig. S48†). The self-assembled block copoly-
mer micelles could also be degraded enzymatically in aqueous
solvent with solid-supported lipase. For this purpose, mPEG48-
b-P(MDO)71 micelles were prepared at a concentration of
approx. 15 mg mL−1 in 10× PB (prepared from D2O with 1%
dimethyl sulfone (DMS) as the internal standard; dimethyl
sulfone was chosen as the reference, because the chemical
shift is far apart from any relevant resonance signal; further-
more, it is highly hydrophilic, which minimizes potential
interactions with the enzyme or micelles during degradation).
20 mg of Novozyme 435 per 1 mg of the polymer was added
into the NMR tube. The resin floated on top of the sample
and, therefore, did not interfere with the NMR measurement.
At periodic intervals, NMR spectra were recorded and analysed
(compare Fig. S48†).
(c) Enzymatic DLS degradation kinetics (Fig. 5 and
Fig. S49†). Enzymatic micelle degradation could also be fol-
lowed by DLS, as solid-supported lipase beads float on top of
the aqueous medium inside the DLS cuvette. For this purpose,
micelles were prepared as described by the direct hydration
technique at a concentration of 4 mg mL−1. Subsequently,
93.70 mg of Novozyme 435 were added to 900 µL of the micel-
lar solution inside the cuvette and degradation was monitored
via DLS. A sample without lipase served as the reference.
Between each measuring time point, sealed samples were
shaken on an orbital lab shaker.
2.9 Encapsulation and release of Nile Red into
mPEG-b-poly(MDO) block copolymer micelles
(a) Nile Red formulation. In order to target a theoretical
loading of 2.5 wt% of Nile Red, approx. 4 mg polymer was
weighed in a 5 mL Eppendorf tube and dissolved in an appro-
priate volume of a Nile Red stock solution (c = 0.111 mg mL−1
in acetonitrile). Subsequently, the solvent was removed under
vacuum over 2.5 h, resulting in a thin layer of Nile Red and
mPEG-b-poly(MDO) covering the Eppendorf tube which
enables a fast dissolution afterwards. 120 mM phosphate
buﬀer was added targeting a polymer concentration of
4 mg mL−1. Self-assembly and dye loading were assisted by
sonication at 0 °C for 30 minutes. After sonication, the par-
ticles were filtered via a GHP-filter with a pore size of 0.45 µm.
The filtration step removed the precipitated dye, which was not
encapsulated. After filtration, a pink solution without any
visible precipitation was obtained. In analogy, reference
samples were prepared that contained only the polymer or
only Nile Red and served as blank probes (Fig. S50†). Directly
after preparation, the micelles were analysed by DLS and UV/
Vis spectroscopy.
(b) Quantification of Nile Red loaded into mPEG-b-poly
(MDO) block copolymer micelles. Taking the particle self-
absorbance due to micelle scattering into account, blank
polymer micelle samples without a dye were subtracted from
the UV/Vis absorption obtained for the loaded particles. The
pH of the dye-loaded micellar solution was at 7.13. The
measured absorbance spectra of micelles formulated with and
without Nile Red are shown in Fig. 6. Nile Red loading could
be quantified by comparison to an external calibration curve
(Fig. S51 and S52†).
(c) Nile Red release. To investigate the kinetics of Nile Red
release, the absorbance spectra of dye loaded micelles were
recorded over time. Additionally, particle size distribution was
recorded by DLS. For this purpose, micelles loaded with Nile
Red were prepared as described above. For enzymatic degra-
dation and dye release, 101.71 mg of Novozyme 435 were
added to 1000 µL of loaded micelle solution inside the cuvette
and degradation was monitored via both DLS and UV/Vis. A
sample without an enzyme served as the reference. Between
each measuring time point, sealed samples were shaken on
the orbital lab shaker.
2.10 Formulation of TLR 7 agonist Adifectin loaded mPEG-b-
poly(MDO) block copolymer micelles
For formulations with the amphiphilic polymers, 500 µg
Adifectin was diluted with 500 µL ethanol targeting a concen-
tration of 1 mg mL−1. 128 µL of this stock solution was trans-
ferred each into two diﬀerent 15 mL tubes, where one of them
contained 4 mg of mPEG48-b-PMDO50. Both probes were sub-
sequently freed from the solvent under reduced pressure,
resulting in thin films covering the tube bottom. As described
by the supplier, Adifectin itself was dissolved in ethanol, tar-
geting a concentration of 10 µg µL−1 and vortexed. Once solu-
bilized, the solution was diluted with 120 mM phosphate
buﬀer to provide a 0.1 mM theoretical Adifectin solution and
sonicated for 30 minutes. The formulation with the polymer
was treated similarly. All samples were filtered through GHP-
filters with a pore size of 0.45 µm. The prepared formulations
were measured via DLS and the Adifectin concentration was
quantified by UV/Vis spectroscopy.
2.11 Quantification of Adifectin loaded into mPEG-b-poly
(MDO) block copolymer micelles
In analogy to the quantification of Nile Red loading, the
Adifectin concentration was determined by comparison to an
external standard curve in ethanol (Fig. S61A + B†). Adifectin
shows a peak maximum at 297 nm. The scattering absorbance
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of unloaded particles was subtracted from the UV/Vis absorp-
tion value obtained for the loaded particles (Fig. S61C†).
2.12 Raw Blue macrophage cell culturing
RAW-Blue macrophages were cultured in Dulbecco’s modified
Eagle’s medium (DMEM) supplemented with 10% fetal bovine
serum, 1% penicillin/streptomycin, 0.02% Normocin and
0.01% Zeocin at 37 °C with 5% CO2 saturation.
2.13 TLR 7 stimulation assay
Adifectin TLR receptor stimulation followed by NF-kB/AP-1
activation (detected by the secretion of embryonic alkaline
phosphatase) was performed on RAW-Blue cells as rec-
ommended by the manufacturer (InvivoGen). RAW-Blue cells
were seeded into 96-well plates at a density of 90 000 cells per
well in 180 μL culture medium. The cells adhered overnight
and then they were treated in each well with 20 μL of the
sample at given Adifectin concentrations (listed in Table S2†).
After stimulation for 16 h, 50 μL of the supernatant from each
well was collected and probed for secreted embryonic alkaline
phosphatase (SEAP) using the QUANTI-Blue assay (InvivoGen).
150 μL QUANTI-Blue was added to each sample and incubated
at 37 °C. Secretion of embryonic alkaline phosphatase levels were
determined by measuring the optical density at 650 nm using the
microplate reader. Activity was determined by an increase in the
optical density relative to the negative control treated with PBS.
The TLR 7/8 agonist 1-(4-(aminomethyl)benzyl)-2-butyl-1H-
imidazo[4,5-c]quinolin-4-amine (IMDQ) served as a positive
control, as used in previous experiments.12–14 A minimal inter-
ference between the 120 mM phosphate buﬀer and the SEAP
assay was observed, due to an increased phosphate con-
centration. Therefore, the obtained results were corrected based
on the contribution of the 120 mM phosphate buﬀer blank and
the PBS blank. All experiments were conducted in quadruplicate
(n = 4).
2.14 Cell viability assay
50 µL of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide (MTT) (0.5 mg mL−1 in PBS) was added to the
RAW-Blue macrophages that were treated with the corres-
ponding samples at given Adifectin/polymer concentrations.
After MTT incubation for 3 h, the formazan crystals formed
were dissolved by the addition of 100 μL of 10% m/v SDS/0.01
M HCl and incubated overnight at 37 °C. Quantification was
done by measuring the absorbance at 570 nm using the micro-
plate reader. Cell viability was calculated in relation to positive
(blank PBS, referred to as 100% viability) and negative (10%
DMSO, referred to as 0% viability) control samples. All experi-
ments were conducted in quadruplicate (n = 4).
3. Results and discussion
Among diﬀerent classes of amphiphilic polymers used for
drug delivery, only a few guarantee full fragmentation into
small molecules upon exposure to external stimuli. Poly(estera-
cetal)s can provide such degradation features towards variation
in pH both below and above physiological values. While the
ester group in the backbone is prone to basic hydrolysis or
enzymatic degradation, the additional acetal group enables
acid triggered depolymerisation occurring in tumour microen-
vironments and their draining lymph nodes, as well as intra-
cellularly inside endolysosomes. To the best of our knowledge,
polymerising hydrophobic poly(esteracetal)s onto hydrophilic
polymers providing amphiphilic poly(esteracetal)s has not
been reported before and will be examined in this work with
respect to applications in immunodrug delivery.
3.1 MDO monomer synthesis
According to the literature,17 the cyclic esteracetal-monomer
2-methyl-1,3-dioxan-4-one (MDO) was synthesized from
racemic 2-methyldihydrofuran-3-one via Baeyer–Villiger oxi-
dation. The purified product was dried over calcium hydride
and distilled under vacuum. The compound was obtained as a
colourless liquid with a yield of 59%. The structure of the
product could be validated by 1H-NMR, 13C-NMR, COSY- and
HSQC-NMR spectroscopy and the results are shown in Fig. S1–
S4.† As we observed that MDO slowly degraded over time into
3-hydroxypropanoic acid and acetaldehyde, it was stored at
−18 °C and always distilled freshly prior to use.
3.2 Homopolymerisation of poly(MDO)
Hillmyer et al. have previously evaluated the ring-opening
homopolymerisation of MDO using diphenyl phosphoric acid
(DPP) as an organic catalyst.18 Attributed to low thermo-
dynamic driving forces for ring-opening of MDO and achieve
equilibrium conditions during polymerisation, reaction con-
ditions at high dilutions prohibit high monomer conversion.
Therefore, Hillmyer et al. performed homopolymerisations in
the bulk.18,20 These conditions seem to be primarily diﬃcult
for later block copolymerisations. Accordingly, MDO poly-
merisation conditions are required which take into account
both solubility and dilution by a macroinitiator.
To address this question, we initially tested polymerisation
at 7 M monomer dilution using pyrene butanol as the initiator
(compared to ∼10 M in the bulk).17 Polymer purification was
performed as described by Hillmyer et al. via precipitation in
hexane THF (9 : 1) and subsequent drying under reduced
pressure at room temperature. Poly(pyrene butanol-P(MDO))
was characterised by NMR, SEC and MALDI-ToF MS (Fig. S5–
S12†). 1H-NMR analysis confirmed successful ring-opening of
the cyclic monomer. The characteristic quartet resonance
signal at 5.96 ppm verified the incorporation of poly(esterace-
tal)s into the polymer backbone.17,18 Signals corresponding to
the pyrene butanol end group were found in the 1H-NMR spec-
trum, too (with the assistance of the 1H-NMR derived
COSY-NMR spectrum, because some relevant pyrene butanol
signals were partially covered by other resonance signals –
compare Fig. S7†).
By size exclusion chromatography (SEC) we observed
reasonably narrow dispersities and in the elugrams UV absorp-
tion emerged nearly simultaneously with the refractive index
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(Fig. S11†), which confirmed that pyrene butanol was present
as an end group on the poly(esteracetal)s (note that poly(ester-
acetal)s themselves are not UV active).
In accordance with that, we could find intact MDO
monomer repeating units (116 g mol−1) by MALDI ToF mass
spectrometry. A comparison with simulated mass peaks sup-
ported successful integration of one pyrene butanol as an end
group onto mostly multimeric esteracetal moieties and only
minor (one or two) integration of ester units into the backbone
(Fig. S12†). Interestingly, comparatively small mass peaks
matched the formation of cyclic homopolymers without any
pyrene butanol end group. As rationalized by others, these
concurring side reactions can hardly be suppressed
completely under the applied reaction conditions.18,21 MDO
can polymerise after self-initiation via an activated chain end
mechanism into either homopolymers with an enol ester end
group or a cyclized product. Based on their similar molecular
weights MALDI-ToF MS cannot diﬀerentiate between polymers
terminated by an enol ester end group and cyclized polymers.
In fact, only a minor formation of such a product was found in
the mass spectra (Fig. S12†); however, by 1H-NMR spectroscopy
no enol ester signals were observed. Instead, only esteracetal
protons of the cyclized side products were detectable (the
signals overlap with the pyrene butanol end group derived
acetal signal – Fig. S5 and S6†).
Taken together, the combined results from 1H-NMR, SEC
and MALDI-ToF MS analyses confirmed that the synthesis of
pyrene butanol initiated poly(MDO) can be achieved under
slightly diluted conditions in the presence of solvents. For
equilibrium polymerisation conditions, the overall observed
conversion should decrease at higher dilution compared to
bulk polymerisation. Alternatively, reduced temperatures
would thermodynamically favour higher conversions. We,
therefore, performed also polymerisations at 0 °C, and indeed
higher conversions could be found at longer reaction times;
yet, we also observed broader molecular weight distribution
(PDI increased from 1.31 to 1.79). We attribute this to lower
viscosities at these temperatures that might further be aﬀected
by the presence of polymers. The latter would be more relevant
for block copolymerisations using mPEG macroinitiators.
To conclude, polymerisations at room temperature and
monomer dilutions at 7 M seem to result in acceptable
product formation and were, therefore, applied in the follow-
ing block copolymerisation reactions.
3.3 Block copolymerisation of mPEG-b-poly(MDO)
A variety of amphiphilic block copolymers were synthesized by
polymerising MDO onto mPEG48 (2000 g mol
−1). mPEG is
commonly used as a hydrophilic, non-toxic coating for nano-
medicines, because its stealth-like properties prevent opsonisa-
tion and plasma protein binding, increase colloidal stability
and prolong circulation half-life.22 For polymerising MDO
onto it, we applied the previous conditions of homopolymeri-
sation. With respect to high monomer concentrations for
MDO ring-opening, the diluting eﬀect of the macroinitiator
mPEG needs to be taken into account. We, therefore, adapted
the solvent volume targeting a concentration between 7 M and
8 M (the mPEG-density was assumed to contribute only by its
solid density). It was necessary to dissolve the macroinitiator-
mPEG first in the monomer to ensure suﬃcient mixing before
the DPP catalyst was added (pre-dissolved in the remaining
solvent).
By varying the monomer to initiator ratio, we could target
diﬀerent poly(MDO) block lengths. Conversion of MDO was
tracked by 1H-NMR. After 23 h, an equilibrium was reached
(further conversion was marginal) and, consequently, the poly-
merisation was quenched with triethylamine. In order to find
an appropriate purification method, previously conducted
solubility experiments with pyrene butanol initiated homopo-
lymers indicated that they are slightly soluble in diethyl ether,
whereas mPEG does precipitate well. Therefore, the crude
product was subsequently precipitated in Et2O three times at
−17 °C. We obtained diﬀerent PMDO block lengths at poly-
merisation degrees between 15 and 71 relative to the mPEG
units. The obtained results are summarized in Table 1.
1H-, 13C- and 2D-NMR analyses confirmed the successful
formation of mPEG-poly(esteracetal) block copolymers in all
cases and the absence of major impurities. As an example, the
1H-NMR spectrum of mPEG48-b-P(MDO)50 is shown in Fig. 2A
Fig. 2 Characterisation of amphiphilic mPEG-b-PMDO block copoly-
mers. A: 1H NMR (400 MHz) of mPEG48-b-PMDO50 in CDCl3. Resonance
signals of the macroinitiator and the PMDO block as well as one single
acetal proton between the PEG block and the ﬁrst MDO monomer unit
are annotated. B: SEC elugram of the mPEG48-b-PMDO71 block copoly-
mer (red) and the mPEG48 macro-initiator (blue). C: MALDI-ToF mass
spectra of the mPEG48-b-PMDO15 block copolymer (red) and the
mPEG48 macroinitiator (blue). D:
1H-derived DOSY spectra (400 MHz) of
the mPEG48-b-PMDO71 block copolymer (red) and the mPEG48 macroi-
nitiator (blue).
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while all remaining spectra can be found in the ESI (Fig. S14–
S29,† the degree of polymerisation of the MDO block was
determined based on the integral of the poly(esteracetal)
groups referenced to the ethylene glycol units of mPEG).
Notably, the presence of exactly one single acetal proton signal
can further be observed derived from the ring-opening of the
first MDO monomer unit by mPEG.
We carefully used additional characterisation methods
beyond 1H-NMR spectroscopy to prove successful block copoly-
mer formation, as displayed in Fig. 2B–D. By size exclusion
chromatography (SEC) and by DOSY NMR and MALDI-ToF MS
analyses a distinct shift to higher molecular weights/slower
diﬀusion species was achieved for all block copolymers, while
signals of the remaining unmodified mPEG macroinitiator
were generally absent (Fig. S16, S19, S22 and S25†).
In the MALDI-ToF mass spectra, repetitive MDO (116
g mol−1) and ethylene glycol (44 g mol−1) units can be found
(Fig. S15, S18, S21 and S24†). By detailed analysis and com-
parison with simulated mass signals (Fig. S30†), several mass
peaks can be annotated to block copolymer species and not be
explained by non-modified mPEG or self-initiated P(MDO)
homopolymers.
Taken together, these results clearly demonstrate that poly
(MDO)s can be attached with varying molecular weights onto
mPEG and the resulting amphiphilic poly(esteracetal) block
copolymers are further investigated for their self-assembly and
drug encapsulation performance.
3.4 Block copolymer self-assembly
Generally, nanoparticles within a size range between 10 nm
and 100 nm are considered as ideal drug carrier systems for
several purposes including lymph node targeting after sub-
cutaneous injection.13,23,24 For the latter, such particles would
be large enough to prevent fast clearance by the bloodstream,
but still small enough to provide suﬃcient diﬀusion through
the water channels of the interstitium into the lymphatic
system.
Therefore, we investigated the influence of the hydrophobic
chain length of the mPEG-b-poly(MDO) block copolymers on
their self-assembly behaviour in aqueous media. Note that
poly(MDO) homopolymers alone could not be solubilised in
water after extensive mixing (Fig. S31†). Thus, it was at first
intended to prepare block copolymer micelles via a simple
dialysis-derived solvent switch method, which is most com-
monly used for micelle preparation.25,26 For this purpose, the
block copolymers were dissolved in DMSO and dialyzed
against water. Subsequent DLS measurement revealed aggre-
gates with a size of approximately 100 nm (Fig. S32†).
However, an unusually low scattering intensity implied pre-
liminary degradation during the self-assembly process. In fact,
when dialysis was performed for several days, no particles
could be detected anymore and 1H-NMR proved polymer
degradation to solely mPEG (Fig. S32†).
In this respect, an alternative preparation method had to be
applied to access block copolymer micelles rapidly. It has been
reported that for amphiphilic block copolymers with relatively
low glass temperatures (Tg) for their hydrophobic blocks,
micelles can be prepared via direct hydration.25 Interestingly,
poly(MDO) homopolymers seem to provide such low Tg as the
isolated polymer behaving like a highly viscous liquid (accord-
ing to the literature,17 the Tg is around −30 °C). A direct
hydration without the assistance of further organic solvents is
a fast preparation method and would reduce preliminary
hydrolysis as the hydrophobic domains are immediately forced
into self-assembled and shielded structures in the aqueous
environment. Thus, they would instantaneously be protected
from hydrolysis compared to solvent exchange methods, where
mixtures of organic and aqueous solvents are present during
dialysis and cannot shield the hydrophobic block from degra-
dation immediately.
For the direct hydration formulation, 120 mM phosphate
buﬀer was directly added to the block copolymers and the sub-
sequent dissolution and self-assembly process was assisted by
ultrasonication at 0 °C. Indeed, DLS measurements proved the
formation of micelles at diﬀerent sizes depending on the
length of the hydrophobic block. As shown in Fig. 3, micellar
sizes could be varied from 26 nm to 141 nm depending on the
molecular weight of the P(MDO) block. Moreover, the reprodu-
cibility of the direct hydration formulation method could
further be validated by preparing micelles from mPEG48-b-P
(MDO)50 independently three times. Subsequent DLS measure-
ment always indicated almost identical micelles with similar
sizes and distributions (Fig. S33†).
In addition, the critical micelle concentration (CMC) was
determined for mPEG48-b-P(MDO)15 and mPEG48-b-P(MDO)50
via pyrene fluorescence spectroscopy in order to compare the
influence of the hydrophobic P(MDO) block on the self-assem-
bly behavior. The intensities of pyrene’s first and third vibro-
nic band maxima I1 and I3 at 375 nm and 387 nm varied
depending on the molar block copolymer concentration
(Fig. S34 and S35†). The critical micelle concentration (CMC)
was then estimated by plotting the ratio I3/I1 versus logarithmic
molar polymer concentration (Fig. S36 and S37†). Thereby, for
the mPEG48-b-P(MDO)50 block copolymer with a 3.3-fold larger
P(MDO) block, a 3.3-fold lower CMC could be determined,
Fig. 3 Intensity size distribution plot of polymeric micelles prepared
from mPEG-b-P(MDO) block copolymers of diﬀerent hydrophobic block
lengths via a direct hydration technique.
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which confirms that block copolymer self-assembly is triggered
by the P(MDO) block in aqueous media.
Altogether, the synthesized amphiphilic mPEG-b-P(MDO)
block copolymers show an attractive self-assembling behaviour
and their resulting micellar size ranges are ideal for drug deliv-
ery purposes including passive lymph node delivery.13,23
3.5 Dual pH-responsive degradation
To generally verify the dual pH-responsive degradation profile
of mPEG-b-poly(MDO) block copolymers, micelles were
exposed to acidic and basic conditions in aqueous media and
analysed via 1H-NMR. For this purpose, micelles were prepared
from mPEG48-b-poly(MDO)15 in D2O. Under these conditions,
the poly(MDO) block is not observable (Fig. 4B). However,
30 min after the addition of 5 vol% 1 M HCl or NaOH, more
than 80% of the degradation products appeared in the
1H-NMR spectra. A measurement after 4 hours showed com-
plete degradation, as shown in Fig. 4B. The micelles degrade
into acetaldehyde, 3-hydroxypropanoic acid and mPEG48. Note
that acetaldehyde can afterwards either form a hydrate under
acidic conditions or isomerize to its enol and react further by
aldol condensation under basic conditions (Fig. 4B). All of
these degradation products could be found in the 1H-NMR
spectra. In analogy to these observations, also the elugram of
subsequent SEC measurements proved complete poly(MDO)
block degradation to the remaining hydrophilic mPEG-block,
as shown in Fig. S42.†
To investigate the degradation of the block copolymers on
the micellar self-assembly behaviour, intact micelles were pre-
pared in 120 mM phosphate buﬀer and monitored by DLS
under acidic, neutral and basic conditions. After the integrity
of the micelles was monitored under neutral conditions for up
to two hours, they were treated with either 10 vol% of 1 M
HCL, phosphate buﬀer or 1 M NaOH, respectively. Thereby,
Fig. 4 Dual pH-responsive degradation proﬁle of mPEG-b-P(MDO) derived block copolymer micelles. (A) Scattering intensity observed using DLS
(derived count rate) over time under acidic (pH = 5.7), neutral (pH = 7.2), and basic conditions (pH = 10.8) with photographs of the corresponding
samples inside the cuvette and a proposed mechanism explaining the degradation and self-assembly behaviour. (B) 1H-NMR analysis (400 MHz) of
micelles under neutral conditions and after acidic and basic degradation. Due to the suppressed molecular motion of the P(MDO) block inside the
micellar core, the corresponding proton signals are diminished. Under acidic and basic conditions, micelles degrade into 3-hydroxypropionic acid
and acetaldehyde (note that acetaldehyde can form hydrates under acidic conditions or further isomerize to enols and form aldol adducts at basic
pH).
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the pH dropped to 5.7, remained constant at 7.2 or increased
to 10.8. For the various pH values, a significant drop in the
scattering intensity was found after 2 hours indicating that
micelle degradation under both acidic and basic conditions
was tremendously accelerated (Fig. 4A).
Interestingly, further analyses revealed that under acidic
conditions micelles first formed micrometre-sized aggregates,
as shown by an increase in scattering intensity (Fig. 4A).
Corresponding DLS-derived size distribution curves can be
found in Fig. S38.† This responsive aggregation was also
visible to the naked eye due to the massive increase in turbid-
ity, yet, it disappeared after 2 h completely. We hypothesize
that this aggregation might be a consequence of preliminary
hydrolysis of the stabilising PEG units at the interface between
the hydrophobic cores and their hydrophilic coronas.
Consequently, the hydrophobic domains are not sterically
shielded anymore and, therefore, aggregate into large par-
ticles. To support this hypothesis, we performed zeta potential
measurements immediately after lowering the pH and found
an increase from slightly negative (−13 ± 6 mV) to neutral (−3
± 7 mV) zeta potential values corresponding to a charge neu-
tralization by protonation of the carboxylate groups formed
(Fig. S40†). We schematically depict this behaviour in Fig. 4A.
In contrast, under basic conditions, micelles did not aggre-
gate but gradually fragmentized into smaller particles, as
found from a gradual decrease in the count rate (Fig. 4A) and
from the monitored size distribution plots (Fig. S35†).
Presumably, under basic conditions, the particles are slightly
charged by the deprotonated carboxylic end groups, which
prevent aggregation due to charge repulsion. This could again
be confirmed by zeta potential measurements directly after
increasing the pH, where slightly negative zeta potential values
(−13 ± 6 mV) further dropped to more negative values (−25 ±
6 mV) which contributed to the colloidal stability of the degra-
dation fragments formed in aqueous media (Fig. S40†).
According to preliminary published data suggesting acidic
compartments to be present in compartments of lymph
nodes,15 we want to pinpoint that such pH-responsive aggrega-
tion behaviour might be a promising strategy for tissue-selec-
tive particle trapping.
Micelle stability was also monitored over time under
neutral conditions. In Fig. 4A, a gradual decrease in the light
scattering count rate is observed for mPEG-b-P(MDO) block
copolymers, too, although in a slower fashion. Retained micel-
lar breakdown is desirable because degradation into hydro-
philic small molecules with reasonably low molecular weight
is expected to enable easy renal carrier clearance from the
body, preventing long-term accumulation.27
Comparison of micelles derived from diﬀerent P(MDO)
block lengths showed that those with the shortest P(MDO)
content were already degraded in a few hours (Fig. S41†). We
were able to track their degradation kinetics via 1H-NMR in
phosphate-buﬀered D2O, too, as illustrated in Fig. S43 and
S44.† Interestingly, the kinetics perfectly matched the time-
frames of disassembly observed by DLS as shown in Fig. S41.†
An increased particle stability, however, was confirmed for
block copolymers with increasing hydrophobic block lengths
(Fig. S41†). Micelles from mPEG48-b-P(MDO)50 exhibited a
reasonable stability and combined with their size below
100 nm they were considered most promising for further deliv-
ery purposes.
3.6 Enzymatic degradation
Acid hydrolysis conditions can physiologically occur either
intracellularly (e.g. in endolysosomes at pH levels of up to 5) or
extracellularly (e.g. in immunosuppressive tumour microenvir-
onments or lymph nodes27). Basic pH levels, however, are gen-
erally not reached under physiological conditions; yet, many
hydrolytic esterase enzymes apply base-catalysed mechanisms
to cleave ester bonds. Consequently, we studied poly(MDO)
degradation behaviour in the presence of esterases and chose
lipase as an enzyme with high ester-cleaving activity at hydro-
philic–hydrophobic interfaces.
In first trials, the enzymatic degradation was tested on non-
self-assembling single mPEG-b-P(MDO) poly(esteracetal) block
copolymers. Yet, this could only be conducted in the presence
of organic solvents (Fig. S45†). For this purpose, a recombi-
nant lipase immobilized on acrylic resin beads was used
(Novozyme 435), which facilitates ester cleavage in both
organic (toluene) and aqueous environments according to the
manufacturer. Block copolymer degradation experiments were
performed in toluene-d8 in order to monitor the formation of
small molecular degradation products by 1H-NMR over time
(Fig. S46†). As control samples, mPEG-b-P(MDO) block copoly-
mers were analysed in toluene-d8 without an enzyme, too, and
they proved high polymer stability in organic media over 1
week (Fig. S47†). In the presence of lipase, however, gradual
P(MDO) block degradation was observed from an increase in
the formation of acetaldehyde coupled with a decrease of the
polymeric esteracetal resonance signal (Fig. S46†). According
to the low amount of water present in the toluene reaction
mixture, polymer degradation was not complete and reached
around 50% after 90 h (Fig. S47†). These results motivated us
to perform further lipase degradation experiments also in
buﬀered aqueous media (Fig. 5).
For this purpose, mPEG-b-P(MDO)71 micelles were prepared
in H2O or D2O (supplemented with 120 mM phosphate at pH
7) by the direct hydration method (Fig. 5A). After the addition
of lipase Novozyme 435, accelerated release of 3-hydroxypro-
pionic acid and acetaldehyde (and its hydrate form, respect-
ively) could be detected by 1H-NMR (Fig. 5B). Kinetic monitor-
ing of the 1H-NMR samples over time revealed that already
within the first 1.5 h almost all P(MDO) was hydrolysed into its
small molecular degradation products (Fig. 5C), while in the
control sample without an enzyme these hydrolysis products
could be found gradually (after 90 h the expected amount of
degradation products could be observed, Fig. S48†).
These findings could be well correlated with the scattering
intensities observed during DLS kinetic experiments in the
presence of lipase. The count rates of the formulated mPEG-b-
P(MDO)71 micelles dropped within 2 h dramatically (Fig. 5D),
while a gradual decrease was found for the control samples
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only over a longer time frame (Fig. S49†). Interestingly, in
analogy to the DLS kinetic experiments in the presence of
NaOH, no increase in turbidity or scattering intensity was
found during lipase-mediated degradation in contrast to the
acid-catalysed degradation process at lower pH (Fig. 4A).
Consequently, lipase-mediated P(MDO) degradation probably
follows a similar base-catalysed hydrolysis process, as hypoth-
esized in Fig. 4A (right), and confirms the unique dual pH-
responsive versatility of mPEG-b-P(MDO)-based micelles for
drug delivery purposes.
3.7 Loading and release studies
Ideal micellar-drug delivery systems should be able to encapsu-
late drugs inside their cores and release them upon desired
stimuli that arise at their targeted site of action. To investigate
the encapsulation and release performance of mPEG48-b-P
(MDO)50 derived block copolymer micelles, Nile Red as a
hydrophobic and water-insoluble dye was encapsulated to
mimic hydrophobic drug model compounds (Fig. 6).
Interestingly, the fraction of encapsulated Nile Red can be
quantified by UV/Vis spectroscopy, while non-encapsulated
Nile Red precipitates in water (solubility < 1 µg mL−1) and can
be filtered oﬀ easily (Fig. S50 and S51†).28–31
Micelles formulated with Nile Red were prepared via an
adapted direct hydration method targeting a theoretical
loading of 2.5 wt% of Nile Red. For this purpose, a polymer
film containing Nile Red was first prepared from organic
solvent and evaporated prior to direct hydration of the
mixture. After sonication, the particles were filtered in order to
remove the non-encapsulated, precipitated dye (a schematic
representation of the preparation is shown in Fig. S50†). After
filtration, pink solutions without any visible precipitation were
obtained. In comparison, applying the same procedure to pure
Nile Red but lacking the amphiphilic polymer led to a clear
colourless solution which also showed no characteristic absor-
bance band for Nile Red (compare Fig. 6B and Fig. S50†). The
loaded micelles were subsequently analysed by DLS and an
increase in size confirmed successful dye encapsulation
(Fig. 6C).
Moreover, Nile Red loading could be quantified by UV/Vis
spectroscopy applying an external Nile Red standard curve
determined in ethanol (Fig. S51 and S52†). Pure polymer
micelles served as a reference for absorbance due to particle
scattering (Fig. 6D). Based on the observed findings, a dye
loading eﬃciency of 19% was achieved for the mPEG48-b-P
(MDO)50 derived block copolymer micelles, and it corresponds
to a dye loading of 0.5 wt%. Depending on the length of the
P(MDO) block, drug loading and encapsulation eﬃciency
could also be varied (Fig. S53†). For mPEG48-b-P(MDO)50, only
3.8% of the dye could be encapsulated aﬀording a 0.1 wt% dye
load, while for the larger mPEG48-b-P(MDO)71 polymers with
higher hydrophobic to hydrophilic ratios, 36% of the dye was
formulated into the corresponding micelles aﬀording a
0.9 wt% dye load, as determined by UV/Vis spectroscopy
(Fig. S53†).
In addition, zeta potential measurements were conducted
showing that dye loading hardly aﬀected the zeta potential of
the Nile Red loaded mPEG48-b-P(MDO) micelles. Unloaded
micelles provided a slightly negative zeta potential of −13 ±
6 mV that barely increased upon dye loading to −10 ± 10 mV,
which is not significantly diﬀerent. This behaviour can be
explained by the rather low Nile Red loading below 1 wt%.
Subsequent drug release measurements were conducted
and they correspond to previous particle degradation (compare
Fig. 4A and 5A). After decreasing the pH by addition of HCl,
Nile Red loaded micelles again started to aggregate instan-
taneously, whereas under basic conditions aggregation was
not observed (compare Fig. S55†). Consequently, under acidic
conditions, DLS studies cannot be performed properly to cor-
relate them with Nile Red release. We, therefore, followed the
process visually with the naked eye (Fig. S56†) and observed a
Fig. 5 Lipase-catalysed enzymatic degradation proﬁle of mPEG-b-P
(MDO)71 derived block copolymer micelles. (A) Schematic representation
of lipase mediated micelle degradation of the hydrophobic P(MDO)
block at pH 7. (B) 1H-NMR analysis (400 MHz) of micelles under neutral
conditions before and after the addition of lipase. Due to the suppressed
molecular motion of the P(MDO) block inside the micellar core, the
corresponding polymeric proton signals are ﬁrst diminished; however,
upon addition of lipase, micelles release 3-hydroxypropionic acid and
acetaldehyde (or its hydrate form, respectively). (C) 1H-NMR kinetic ana-
lysis of accelerated enzymatic P(MDO) degradation for mPEG48-b-P
(MDO)71 block copolymer micelles over time in 120 mM phosphate
buﬀer. (D) Scattering intensity kinetics observed using DLS (derived
count rate) of accelerated lipase-mediated P(MDO) degradation of
mPEG48-b-P(MDO)71 block copolymer micelles over time in 120 mM
phosphate buﬀer.
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massive increase in turbidity within the first 6 hours.
Simultaneously, released Nile Red starts to adsorb to the
bottom of the DLS cuvette. After one day, all drug-loaded
micelles were fully degraded and solutions became colourless
with the precipitated dye at the bottom (Fig. 6E and Fig. S56†).
As the UV absorbance of Nile Red is influenced by its
solvation,28–31 UV/Vis spectroscopy can also be used as a tool
to monitor its release from the drug carrier over time.
However, as the decrease in pH significantly influenced par-
ticle aggregation, UV/Vis spectroscopy could not be applied to
those formulations to monitor dye release at acidic pH.
Alternatively, enzymatic degradation in the presence of lipase
at pH 7 did not aﬀord particle aggregation (compare Fig. S57†)
and was, therefore, applied to study dye release kinetics by
both UV/Vis spectroscopy and DLS. Similarly to the findings
shown in Fig. 5D, a rapid decrease in the light scattering count
rate was found for the samples in the presence of lipase, con-
firming again similar degradation behaviour for both empty
and dye loaded micelles (Fig. 6F). In parallel, UV/Vis spec-
troscopy confirmed what was observed visually with the
naked eye (Fig. S57†). A rapid decrease in the Nile Red absor-
bance maximum around 549 nm (compare Fig. 6D) is found
for the dye loaded micelles in the presence of lipase (Fig. 6G)
corresponding to the enzyme-mediated release of Nile
Red from the micelles. Without lipase only a sustained
degradation of mPEG48-b-P(MDO)50 derived block copolymer
micelles (Fig. 6F) corresponding to a gradual release of encap-
sulated Nile Red over time (Fig. 6G) was detected at neutral
pH.
3.8 Application as an immune drug delivery system
Prior to further investigations as suitable drug carriers, the
in vitro cytotoxicity of the mPEG48-b-P(MDO)50 micelles was
studied by MTT-assay on Raw Blue macrophages. Fig. 7D indi-
cates that concentrations up of 400 µg mL−1 did not influence
the viability (compared to PBS buﬀer as a negative control and
10% DMSO as a positive control). Encouraged by these results,
an immunostimulating TLR agonist could be formulated into
mPEG48-b-P(MDO)50 in analogy to Nile Red.
For this purpose, the amphiphilic TLR 7 agonist Adifectin
was selected. Its molecular structure is composed of a hydro-
philic TLR 7 interacting head group, a basic spermine linker
(which might favour additional interaction with the negatively
charged carboxylate end groups of the mPEG48-b-P(MDO)50
block copolymers) and two hydrophobic phytanyl groups that
guarantee interaction with the hydrophobic cores of the
mPEG48-b-P(MDO)50 derived micelles (compare Fig. S58†). It
was fabricated into a polymer film with mPEG48-b-P(MDO)50
and then rehydrated with 120 mM phosphate buﬀer. Adifectin
itself can also be formulated into water according to the manu-
facturer’s guidelines assisted by ethanol. In both cases with
and without mPEG48-b-P(MDO)50, all samples were sonicated
Fig. 6 Nile Red formulated into mPEG48-b-P(MDO)50 micelles. (A) Schematic representation of Nile Red loading and release. Under acidic and basic
conditions, micellar degradation is highly accelerated. Upon degradation, Nile Red is expected to be released and precipitate. (B) Nile Red formulated
with and without the polymer. Pictures are shown before and after ﬁltration (450 µm). Whereas Nile Red formulated with the polymer is stabilized in
solution, Nile Red was solely removed by ﬁltration leading to a clear colourless solution. (C) DLS measurement and (D) UV/Vis absorbance spectra of
micelles formulated with and without Nile Red. (E) Photograph of Nile Red loaded particles before and after degradation. (F) Lipase-mediated enzy-
matic degradation of Nile Red loaded mPEG48-b-P(MDO)71 micelles followed by the light scattering count rate. (G) Lipase-mediated Nile Red release
from mPEG48-b-P(MDO)71 micelles followed by UV-vis absorbance at 549 nm.
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and filtered through GHP-filters of 0.45 µm pore size prior to
use.
Subsequent DLS measurement showed only a slight
increase in micellar size for the loaded micelles, which can be
seen as a first indication of successful immunodrug loading
(Fig. 7B – note that Adifectin is an amphiphile and might
probably be more incorporated into the particle interface than
into the core, thus only slightly contributing to an increase in
size). In addition, the UV/Vis spectrum in Fig. 7C further
proves the successful formulation of Adifectin into the
micelles. The drug load could be quantified by applying an
external calibration curve (Fig. S61†), where micelles prepared
without Adifectin served as a blank sample.
Subsequently, the ability of in vitro immune cell TLR 7 acti-
vation was determined by incubating RAW-Blue macrophages
as the TLR 7 reporter cell line with diﬀerent poly(esteracetal)/
Adifectin concentrations (Table S2†). Interestingly, the
formulation containing the amphiphilic polymer was more
potent compared to the free drug, although the polymer solely
did not show any immune stimulation (Fig. 7E). Additional
quantification of the sample without a block copolymer by
UV/Vis spectroscopy, as shown in Fig. S61,† revealed that the
increased TLR stimulation activity results from an enhanced
ability to solubilise Adifectin during preparation. In fact, the
presence of the amphiphilic mPEG48-b-P(MDO)50 block copoly-
mer promotes the drug’s solubility in water and, thus, its
accessibility to the TLR.
Retrospective correction of the determined Adifectin con-
centration according to Fig. S61† showed that formulations
with mPEG48-b-P(MDO)50 micelles did not lose Adifectin’s
receptor activity and remained almost as potent as the free
drug alone (Fig. S60 and Table S3†).
Furthermore, there was no indication of decreased cell via-
bility on macrophages after treatment with the polymer formu-
lation, as determined by MTT assay (Fig. 7D). Taken together,
these findings suggest that amphiphilic TLR agonists were
safely and eﬃciently formulated by the mPEG-b-P(MDO)50
block copolymers and retained their drug activity on the TLR
receptor in a micellar form. Consequently, the dual pH-degrad-
able mPEG48-b-P(MDO)50 block copolymer system can be con-
sidered as a highly promising approach for such immunodrug
molecules towards possible lymph node focused delivery
strategies.
4. Conclusion
To the best of our knowledge, for the first time a variety of
amphiphilic poly(esteracetal) diblock copolymers could suc-
cessfully be synthesized and studied for their potential as
immunodrug carrier systems.
For this purpose, reaction conditions for the cationic ring-
opening polymerisation of cyclic esteracetal monomer
2-methyl-1,3-dioxan-4-one were optimised and then applied for
block copolymer synthesis with methoxy poly(ethylene glycol)
(mPEG) as the macroinitiator. Successful amphiphilic mPEG-
b-P(MDO) block copolymer formation could be verified by
several NMR and mass spectroscopy techniques as well as SEC
analysis. By varying the monomer to initiator ratio, it was poss-
ible to obtain block copolymers with diﬀerent hydrophobic
block lengths between 15 and 71 monomer units.
All synthesized block copolymers could be self-assembled
into well-defined monomodal micelles by direct hydration.
Their sizes were highly reproducible under these conditions
Fig. 7 Application of P(MDO) derived micelles as an immunodrug delivery system: (A) Schematic representation of drug loading of a TLR 7 agonist
into micelles for drug delivery purposes. (B) Normalized micellar size distribution plot and (C) UV/vis absorbance spectra of micelles with and
without Adifectin. (D) Cellular toxicity analysis of mPEG48-b-PMDO50 on Raw Macrophages determined by MTT assay (n = 4). (E) TLR stimulation
assay on RAW Blue macrophages of Adifectin formulated with and without mPEG48-b-PMDO50. The imiquimod-analogue IDMQ serves as a positive
control and empty micelles provide blank probes with no immunostimulation (n = 4).
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and varied between 26 nm and 141 nm, covering the relevant
size range for immunodrug delivery purposes (e.g. passive
lymph node accumulation). A dual pH-responsive behaviour
towards rapid particle degradation was confirmed by DLS and
1H-NMR. While micelles remained stable at pH 7.2, HCl or
NaOH addition as well as exposure to lipase led to immediate
degradation.
In subsequent drug loading studies, Nile Read as a hydro-
phobic guest molecule could be loaded and released from the
degradable amphiphilic block copolymers eﬃciently. Finally,
first in vitro studies were conducted where no cellular toxicities
were found on macrophages. An amphiphilic TLR-7 agonist
(Adifectin) was co-formulated into the mPEG-b-P(MDO) block
copolymer micelles and its activity was investigated by TLR
stimulation of RAW Blue macrophages. The degradable amphi-
philic block copolymer was able to solubilize Adifectin more
eﬃciently and retained the drug’s activity on the TLR receptor.
These findings suggest that mPEG-b-P(MDO) can be uti-
lized for providing optimized delivery opportunities for prom-
ising immunodrug molecules, also towards possible lymph
node focused delivery. In our ongoing research endeavours, we
will focus on enhancing drug loading and micellar stability at
neutral pH to prevent premature drug release before reaching
its target site.
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